Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengfeng Li

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter StudyJiliang Qiu, Baogang Peng, Yunqiang Tang, et al.
Nature Communications|August 23, 2019
Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasisLixue Cao, Geyan Wu, Jinrong Zhu, et al.
Nature Communications|October 13, 2020
AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradationHan Tian, Rong Lian, Yun Li, et al.
Journal of Virology|November 20, 2025
ZIKV infection causes placental inflammation through activating PANoptosisShuqing Zhang, Delin Chen, Kexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patientsWen Li, Chun-Ping Yu, Jin-tang Xia, et al.
Nature Cell Biology|September 22, 2015
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activationYinghui Li, Qi-Ling Zhou, Wenjie Sun, et al.
Elife|December 17, 2024
Characterization of cancer-driving nucleotides (CDNs) across genes, cancer types, and patientsLingjie Zhang, Tong Deng, Zhongqi Liufu, et al.
NPJ Precision Oncology|March 19, 2026
Organ-metastatic landscape delineates overall and site-specific immune-related adverse events of PD-L1 blockade in advanced NSCLCSi-Heng Wang, Ning Gao, Yu-Ze Wang, et al.
Marine Drugs|June 13, 2012
A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signalingXun Zhu, Zhenjian He, Jueheng Wu, et al.
Bioconjugate Chemistry|March 30, 2012
Dual function of RGD-modified VEGI-192 for breast cancer treatmentJueheng Wu, Yi Jiang, Wan Yang, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter StudyJiliang Qiu, Baogang Peng, Yunqiang Tang, et al.
Nature Communications|August 23, 2019
Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasisLixue Cao, Geyan Wu, Jinrong Zhu, et al.
Nature Communications|October 13, 2020
AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradationHan Tian, Rong Lian, Yun Li, et al.
Journal of Virology|November 20, 2025
ZIKV infection causes placental inflammation through activating PANoptosisShuqing Zhang, Delin Chen, Kexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patientsWen Li, Chun-Ping Yu, Jin-tang Xia, et al.
Nature Cell Biology|September 22, 2015
Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activationYinghui Li, Qi-Ling Zhou, Wenjie Sun, et al.
Elife|December 17, 2024
Characterization of cancer-driving nucleotides (CDNs) across genes, cancer types, and patientsLingjie Zhang, Tong Deng, Zhongqi Liufu, et al.
NPJ Precision Oncology|March 19, 2026
Organ-metastatic landscape delineates overall and site-specific immune-related adverse events of PD-L1 blockade in advanced NSCLCSi-Heng Wang, Ning Gao, Yu-Ze Wang, et al.
Marine Drugs|June 13, 2012
A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signalingXun Zhu, Zhenjian He, Jueheng Wu, et al.
Bioconjugate Chemistry|March 30, 2012
Dual function of RGD-modified VEGI-192 for breast cancer treatmentJueheng Wu, Yi Jiang, Wan Yang, et al.
Pageof 15